What is the effect of treating OSA on longer-term outcomes of mortality and morbidity in patients with HF?
Although no randomized trials have been performed to evaluate the effect of treatment of OSA on longer-term outcomes of mortality and morbidity in patients with HF, smaller short-term studies have suggested that treatment of OSA with continuous positive airway pressure is associated with an improvement in EF, dyspnea, and QOL in patients with HFrEF and in BP, diastolic function, and cardiac remodeling in patients with HFpEF.